Fig. 2From: Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat modelsCCR2 reduces bone resorption in MIA rat. A Bone samples were collected from MIA induced right knee at 14 day. Samples were scanned using mCT. B Bone volume, bone surface, structure thickness (st.th) and structure separation (st.sp) subchondral bone were measured to the BoneJ. The data show the mean ± SEM of three independent experiments. (*p < 0.05)Back to article page